Governors Lane’s Cidara Therapeutics CDTX Stock Holding History

Governors Lane’s Portfolio CDTX Stock Details CDTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-62,325	Closed	-$13.8M	–	201
2025 Q4	$13.8M	Buy	+62,325	New	+$10.1M	0.82%	27

Governors Lane's CDTX Position: Q1 2026 in Review

Governors Lane sold out of Cidara Therapeutics (CDTX) in Q1 2026, closing a stake of 62,325 shares — an estimated $13.8M sold.

Governors Lane first reported a position in CDTX in Q4 2025 and held it in 1 quarter. The position peaked at $13.8M in Q4 2025. 0 funds tracked by Wall St. Rank hold CDTX as of Q1 2026.

Governors Lane reported no remaining Cidara Therapeutics position as of Q1 2026 after selling out during the quarter.
Governors Lane sold 62,325 Cidara Therapeutics shares in Q1 2026, an estimated $13.8M.
Governors Lane first reported a position in Cidara Therapeutics in Q4 2025 and held it in 1 quarter.
Governors Lane's Cidara Therapeutics position peaked at $13.8M in Q4 2025.
0 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q1 2026.

Based on Governors Lane's 13F filing for Q1 2026, filed 15 May 2026.